Molina Healthcare (MOH) to Release Earnings on Wednesday

Molina Healthcare (NYSE:MOH) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, October 23rd. Analysts expect Molina Healthcare to post earnings of $6.02 per share for the quarter. Molina Healthcare has set its FY24 guidance at $23.50 EPS and its FY 2024 guidance at 23.500- EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share for the quarter, topping analysts’ consensus estimates of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The business had revenue of $9.88 billion for the quarter, compared to analysts’ expectations of $9.75 billion. During the same period in the prior year, the company posted $5.65 EPS. The business’s revenue for the quarter was up 18.7% on a year-over-year basis. On average, analysts expect Molina Healthcare to post $24 EPS for the current fiscal year and $27 EPS for the next fiscal year.

Molina Healthcare Trading Down 1.1 %

Shares of MOH opened at $286.52 on Tuesday. The firm’s 50-day moving average is $338.57 and its two-hundred day moving average is $331.56. The firm has a market capitalization of $16.79 billion, a P/E ratio of 15.55, a PEG ratio of 1.15 and a beta of 0.58. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.49. Molina Healthcare has a twelve month low of $282.96 and a twelve month high of $423.92.

Insider Buying and Selling at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares in the company, valued at approximately $6,114,260.25. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CAO Maurice Hebert sold 393 shares of the firm’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the sale, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at approximately $3,282,583.96. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the sale, the director now directly owns 18,025 shares in the company, valued at $6,114,260.25. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have weighed in on the company. TD Cowen lowered their target price on Molina Healthcare from $412.00 to $351.00 and set a “buy” rating on the stock in a report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Molina Healthcare from $354.00 to $353.00 and set a “hold” rating on the stock in a research report on Monday, July 29th. Stephens restated an “equal weight” rating and set a $320.00 price objective on shares of Molina Healthcare in a research report on Thursday, July 25th. Jefferies Financial Group dropped their price target on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating for the company in a research report on Wednesday, July 24th. Finally, Truist Financial dropped their price objective on Molina Healthcare from $440.00 to $400.00 and set a “buy” rating for the company in a research report on Monday, July 15th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $378.00.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.